First Zantac Cancer Risk Trial in California Postponed by Months

The first scheduled trial over claims that GSK's heartburn drug Zantac caused cancer, which had been set to begin Monday, has been postponed, likely by several months.
Reuters Health Information

source https://www.medscape.com/viewarticle/988802?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?